Literature DB >> 19646678

Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene.

Paul Renbaum1, Efrat Kellerman, Ranit Jaron, Dan Geiger, Reeval Segel, Ming Lee, Mary Claire King, Ephrat Levy-Lahad.   

Abstract

The spinal muscular atrophies (SMAs) are a genetically and clinically heterogeneous group of disorders characterized by degeneration and loss of anterior horn cells in the spinal cord, leading to muscle weakness and atrophy. Spinal muscular atrophy with pontocerebellar hypoplasia (SMA-PCH, also known as pontocerebellar hypoplasia type 1 [PCH1]) is one of the rare infantile SMA variants that include additional clinical manifestations, and its genetic basis is unknown. We used a homozygosity mapping and positional cloning approach in a consanguineous family of Ashkenazi Jewish origin and identified a nonsense mutation in the vaccinia-related kinase 1 gene (VRK1) as a cause of SMA-PCH. VRK1, one of three members of the mammalian VRK family, is a serine/threonine kinase that phosphorylates p53 and CREB and is essential for nuclear envelope formation. Its identification as a gene involved in SMA-PCH implies new roles for the VRK proteins in neuronal development and maintenance and suggests the VRK genes as candidates for related phenotypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19646678      PMCID: PMC2725266          DOI: 10.1016/j.ajhg.2009.07.006

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  Exact genetic linkage computations for general pedigrees.

Authors:  M Fishelson; D Geiger
Journal:  Bioinformatics       Date:  2002       Impact factor: 6.937

2.  Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription.

Authors:  T Shimohata; T Nakajima; M Yamada; C Uchida; O Onodera; S Naruse; T Kimura; R Koide; K Nozaki; Y Sano; H Ishiguro; K Sakoe; T Ooshima; A Sato; T Ikeuchi; M Oyake; T Sato; Y Aoyagi; I Hozumi; T Nagatsu; Y Takiyama; M Nishizawa; J Goto; I Kanazawa; I Davidson; N Tanese; H Takahashi; S Tsuji
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

Review 3.  An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).

Authors:  B Wirth
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

4.  Disruption of CREB function in brain leads to neurodegeneration.

Authors:  Theo Mantamadiotis; Thomas Lemberger; Susanne C Bleckmann; Heidrun Kern; Oliver Kretz; Ana Martin Villalba; François Tronche; Christoph Kellendonk; Daniel Gau; Josef Kapfhammer; Christiane Otto; Wolfgang Schmid; Günther Schütz
Journal:  Nat Genet       Date:  2002-04-22       Impact factor: 38.330

5.  A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy.

Authors:  Philip J Young; Patricia M Day; Jianhua Zhou; Elliot J Androphy; Glenn E Morris; Christian L Lorson
Journal:  J Biol Chem       Date:  2001-11-09       Impact factor: 5.157

6.  Extended phenotype of pontocerebellar hypoplasia with infantile spinal muscular atrophy.

Authors:  Sabine Rudnik-Schöneborn; László Sztriha; Gururaj R Aithala; Gunnar Houge; Liv M Laegreid; Jürgen Seeger; Michael Huppke; Brunhilde Wirth; Klaus Zerres
Journal:  Am J Med Genet A       Date:  2003-02-15       Impact factor: 2.802

7.  tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia.

Authors:  Birgit S Budde; Yasmin Namavar; Peter G Barth; Bwee Tien Poll-The; Gudrun Nürnberg; Christian Becker; Fred van Ruissen; Marian A J Weterman; Kees Fluiter; Erik T te Beek; Eleonora Aronica; Marjo S van der Knaap; Wolfgang Höhne; Mohammad Reza Toliat; Yanick J Crow; Maja Steinling; Thomas Voit; Filip Roelenso; Wim Brussel; Knut Brockmann; Marten Kyllerman; Eugen Boltshauser; Gerhard Hammersen; Michèl Willemsen; Lina Basel-Vanagaite; Ingeborg Krägeloh-Mann; Linda S de Vries; Laszlo Sztriha; Francesco Muntoni; Colin D Ferrie; Roberta Battini; Raoul C M Hennekam; Eugenio Grillo; Frits A Beemer; Loes M E Stoets; Bernd Wollnik; Peter Nürnberg; Frank Baas
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

8.  VRK1 phosphorylates CREB and mediates CCND1 expression.

Authors:  Tae-Hong Kang; Do-Young Park; Wanil Kim; Kyong-Tai Kim
Journal:  J Cell Sci       Date:  2008-08-19       Impact factor: 5.285

9.  Characterization of three paralogous members of the Mammalian vaccinia related kinase family.

Authors:  R Jeremy Nichols; Paula Traktman
Journal:  J Biol Chem       Date:  2003-11-25       Impact factor: 5.157

10.  Barrier-to-autointegration factor plays crucial roles in cell cycle progression and nuclear organization in Drosophila.

Authors:  Kazuhiro Furukawa; Shin Sugiyama; Shinichi Osouda; Hidemasa Goto; Masaki Inagaki; Tsuneyoshi Horigome; Saburo Omata; Maeve McConnell; Paul A Fisher; Yasuyoshi Nishida
Journal:  J Cell Sci       Date:  2003-08-05       Impact factor: 5.285

View more
  62 in total

1.  Mutations in VRK1 associated with complex motor and sensory axonal neuropathy plus microcephaly.

Authors:  Claudia Gonzaga-Jauregui; Timothy Lotze; Leila Jamal; Samantha Penney; Ian M Campbell; Davut Pehlivan; Jill V Hunter; Suzanne L Woodbury; Gerald Raymond; Adekunle M Adesina; Shalini N Jhangiani; Jeffrey G Reid; Donna M Muzny; Eric Boerwinkle; James R Lupski; Richard A Gibbs; Wojciech Wiszniewski
Journal:  JAMA Neurol       Date:  2013-12       Impact factor: 18.302

Review 2.  The genetics of cerebellar malformations.

Authors:  Kimberly A Aldinger; Dan Doherty
Journal:  Semin Fetal Neonatal Med       Date:  2016-05-07       Impact factor: 3.926

3.  Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage.

Authors:  Marta Sanz-García; Diana M Monsalve; Ana Sevilla; Pedro A Lazo
Journal:  J Biol Chem       Date:  2012-05-22       Impact factor: 5.157

4.  Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function.

Authors:  Ender Karaca; Stefan Weitzer; Davut Pehlivan; Hiroshi Shiraishi; Tasos Gogakos; Toshikatsu Hanada; Shalini N Jhangiani; Wojciech Wiszniewski; Marjorie Withers; Ian M Campbell; Serkan Erdin; Sedat Isikay; Luis M Franco; Claudia Gonzaga-Jauregui; Tomasz Gambin; Violet Gelowani; Jill V Hunter; Gozde Yesil; Erkan Koparir; Sarenur Yilmaz; Miguel Brown; Daniel Briskin; Markus Hafner; Pavel Morozov; Thalia A Farazi; Christian Bernreuther; Markus Glatzel; Siegfried Trattnig; Joachim Friske; Claudia Kronnerwetter; Matthew N Bainbridge; Alper Gezdirici; Mehmet Seven; Donna M Muzny; Eric Boerwinkle; Mustafa Ozen; Tim Clausen; Thomas Tuschl; Adnan Yuksel; Andreas Hess; Richard A Gibbs; Javier Martinez; Josef M Penninger; James R Lupski
Journal:  Cell       Date:  2014-04-24       Impact factor: 41.582

5.  Biallelic variants in AGTPBP1, involved in tubulin deglutamylation, are associated with cerebellar degeneration and motor neuropathy.

Authors:  Ruth Sheffer; Michal Gur; Rebecca Brooks; Somaya Salah; Muhannad Daana; Nitay Fraenkel; Eli Eisenstein; Malcolm Rabie; Yoram Nevo; Chaim Jalas; Orly Elpeleg; Shimon Edvardson; Tamar Harel
Journal:  Eur J Hum Genet       Date:  2019-04-11       Impact factor: 4.246

6.  Homozygous Mutations in TBC1D23 Lead to a Non-degenerative Form of Pontocerebellar Hypoplasia.

Authors:  Isaac Marin-Valencia; Andreas Gerondopoulos; Maha S Zaki; Tawfeg Ben-Omran; Mariam Almureikhi; Ercan Demir; Alicia Guemez-Gamboa; Anne Gregor; Mahmoud Y Issa; Bart Appelhof; Susanne Roosing; Damir Musaev; Basak Rosti; Sara Wirth; Valentina Stanley; Frank Baas; Francis A Barr; Joseph G Gleeson
Journal:  Am J Hum Genet       Date:  2017-08-17       Impact factor: 11.025

7.  TSEN54 mutations cause pontocerebellar hypoplasia type 5.

Authors:  Yasmin Namavar; David Chitayat; Peter G Barth; Fred van Ruissen; Marit B de Wissel; Bwee Tien Poll-The; Rachel Silver; Frank Baas
Journal:  Eur J Hum Genet       Date:  2011-02-02       Impact factor: 4.246

8.  Garrod's fourth inborn error of metabolism solved by the identification of mutations causing pentosuria.

Authors:  Sarah B Pierce; Cailyn H Spurrell; Jessica B Mandell; Ming K Lee; Sharon Zeligson; Michael S Bereman; Sunday M Stray; Siv Fokstuen; Michael J MacCoss; Ephrat Levy-Lahad; Mary-Claire King; Arno G Motulsky
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

9.  Review of Spinal Muscular Atrophy (SMA) for Prenatal and Pediatric Genetic Counselors.

Authors:  Amanda Carré; Candice Empey
Journal:  J Genet Couns       Date:  2015-08-08       Impact factor: 2.537

10.  Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations.

Authors:  Sabine Rudnik-Schöneborn; Jan Senderek; Joanna C Jen; Gunnar Houge; Pavel Seeman; Alena Puchmajerová; Luitgard Graul-Neumann; Ulrich Seidel; Rudolf Korinthenberg; Janbernd Kirschner; Jürgen Seeger; Monique M Ryan; Francesco Muntoni; Maja Steinlin; Laszlo Sztriha; Jaume Colomer; Christoph Hübner; Knut Brockmann; Lionel Van Maldergem; Manuel Schiff; Andreas Holzinger; Peter Barth; William Reardon; Michael Yourshaw; Stanley F Nelson; Thomas Eggermann; Klaus Zerres
Journal:  Neurology       Date:  2013-01-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.